AMNEAL PHARMACEUTICALS (AMRX) Competitors $10.36 -0.08 (-0.72%) As of 12:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMRX vs. RDY, VTRS, ROIV, BBIO, MRNA, QGEN, ELAN, VRNA, RVMD, and ABVXShould you be buying AMNEAL PHARMACEUTICALS stock or one of its competitors? The main competitors of AMNEAL PHARMACEUTICALS include Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Roivant Sciences (ROIV), BridgeBio Pharma (BBIO), Moderna (MRNA), QIAGEN (QGEN), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), and Abivax (ABVX). These companies are all part of the "pharmaceutical products" industry. AMNEAL PHARMACEUTICALS vs. Its Competitors Dr. Reddy's Laboratories Viatris Roivant Sciences BridgeBio Pharma Moderna QIAGEN Elanco Animal Health Verona Pharma PLC American Depositary Share Revolution Medicines Abivax AMNEAL PHARMACEUTICALS (NASDAQ:AMRX) and Dr. Reddy's Laboratories (NYSE:RDY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability. Does the media refer more to AMRX or RDY? In the previous week, AMNEAL PHARMACEUTICALS had 1 more articles in the media than Dr. Reddy's Laboratories. MarketBeat recorded 2 mentions for AMNEAL PHARMACEUTICALS and 1 mentions for Dr. Reddy's Laboratories. Dr. Reddy's Laboratories' average media sentiment score of 1.78 beat AMNEAL PHARMACEUTICALS's score of 0.54 indicating that Dr. Reddy's Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMNEAL PHARMACEUTICALS 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Dr. Reddy's Laboratories 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is AMRX or RDY more profitable? Dr. Reddy's Laboratories has a net margin of 16.99% compared to AMNEAL PHARMACEUTICALS's net margin of 0.12%. Dr. Reddy's Laboratories' return on equity of 17.25% beat AMNEAL PHARMACEUTICALS's return on equity.Company Net Margins Return on Equity Return on Assets AMNEAL PHARMACEUTICALS0.12% -189.49% 6.17% Dr. Reddy's Laboratories 16.99%17.25%11.63% Which has more volatility & risk, AMRX or RDY? AMNEAL PHARMACEUTICALS has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, Dr. Reddy's Laboratories has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500. Do analysts recommend AMRX or RDY? AMNEAL PHARMACEUTICALS presently has a consensus target price of $12.00, suggesting a potential upside of 15.89%. Dr. Reddy's Laboratories has a consensus target price of $16.95, suggesting a potential upside of 16.06%. Given Dr. Reddy's Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Dr. Reddy's Laboratories is more favorable than AMNEAL PHARMACEUTICALS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AMNEAL PHARMACEUTICALS 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Dr. Reddy's Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83 Do insiders & institutionals hold more shares of AMRX or RDY? 31.8% of AMNEAL PHARMACEUTICALS shares are held by institutional investors. Comparatively, 3.9% of Dr. Reddy's Laboratories shares are held by institutional investors. 26.6% of AMNEAL PHARMACEUTICALS shares are held by insiders. Comparatively, 2.0% of Dr. Reddy's Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable earnings and valuation, AMRX or RDY? Dr. Reddy's Laboratories has higher revenue and earnings than AMNEAL PHARMACEUTICALS. Dr. Reddy's Laboratories is trading at a lower price-to-earnings ratio than AMNEAL PHARMACEUTICALS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAMNEAL PHARMACEUTICALS$2.79B1.16-$116.89M$0.011,035.50Dr. Reddy's Laboratories$3.81B3.20$663M$0.6622.13 SummaryDr. Reddy's Laboratories beats AMNEAL PHARMACEUTICALS on 11 of the 17 factors compared between the two stocks. Get AMNEAL PHARMACEUTICALS News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMRX vs. The Competition Export to ExcelMetricAMNEAL PHARMACEUTICALSMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.25B$2.62B$6.16B$10.65BDividend YieldN/A57.76%5.72%4.86%P/E Ratio1,036.5423.6729.5728.20Price / Sales1.16777.64573.64128.09Price / Cash7.41170.4137.1261.42Price / Book-29.595.3412.226.50Net Income-$116.89M$33.06M$3.32B$276.73M7 Day Performance4.91%-0.48%-0.50%-0.16%1 Month Performance5.23%5.83%5.68%1.37%1 Year Performance24.46%-3.06%68.21%32.60% AMNEAL PHARMACEUTICALS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMRXAMNEAL PHARMACEUTICALS2.5527 of 5 stars$10.36-0.7%$12.00+15.9%+22.7%$3.25B$2.79B1,036.548,100RDYDr. Reddy's Laboratories2.9368 of 5 stars$14.36+0.1%$16.95+18.1%-6.7%$11.97B$3.81B21.7527,811VTRSViatris3.0501 of 5 stars$9.86+1.2%$10.40+5.5%-10.8%$11.36B$14.74B-3.4032,000Analyst ForecastROIVRoivant Sciences2.8895 of 5 stars$16.21+1.1%$19.94+23.0%+53.1%$10.95B$29.05M-23.16860BBIOBridgeBio Pharma4.5827 of 5 stars$55.96+0.8%$63.94+14.3%+113.5%$10.61B$221.90M-13.68400Analyst ForecastMRNAModerna4.2622 of 5 stars$26.74-0.3%$41.81+56.4%-49.7%$10.48B$3.24B-3.555,800Trending NewsAnalyst ForecastGap DownQGENQIAGEN4.1454 of 5 stars$47.30+1.0%$49.40+4.4%+18.4%$10.41B$1.98B27.955,765Positive NewsELANElanco Animal Health2.7271 of 5 stars$20.04+1.4%$19.14-4.5%+70.9%$9.82B$4.44B23.309,000Analyst ForecastVRNAVerona Pharma PLC American Depositary Share1.0772 of 5 stars$106.91flat$109.00+2.0%N/A$9.21B$42.28M-107.9930Positive NewsRVMDRevolution Medicines4.3018 of 5 stars$48.75+1.1%$74.64+53.1%+12.4%$9.02B$11.58M-10.83250News CoverageAnalyst UpgradeABVXAbivax3.4727 of 5 stars$95.63+2.0%$114.25+19.5%+763.9%$7.30BN/A0.0061Short Interest ↓ Related Companies and Tools Related Companies RDY Competitors VTRS Competitors ROIV Competitors BBIO Competitors MRNA Competitors QGEN Competitors ELAN Competitors VRNA Competitors RVMD Competitors ABVX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMRX) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AMNEAL PHARMACEUTICALS, INC. Please log in to your account or sign up in order to add this asset to your watchlist. Share AMNEAL PHARMACEUTICALS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMRX Stock Alerts